Edition:
India

STAAR Surgical Co (STAA.OQ)

STAA.OQ on NASDAQ Stock Exchange Global Market

33.90USD
1:30am IST
Change (% chg)

$1.25 (+3.83%)
Prev Close
$32.65
Open
$32.40
Day's High
$34.15
Day's Low
$32.40
Volume
72,108
Avg. Vol
84,758
52-wk High
$34.45
52-wk Low
$9.90

Latest Key Developments (Source: Significant Developments)

STAAR Surgical Announces Resolution Of FDA Warning Letter
Wednesday, 20 Jun 2018 

June 20 (Reuters) - STAAR Surgical Co ::STAAR SURGICAL ANNOUNCES RESOLUTION OF FDA WARNING LETTER.STAAR SURGICAL CO - RECEIVED CLOSE-OUT LETTER FROM U.S. FDA ON JUNE 19, 2018 LIFTING A WARNING LETTER DATED MAY 21, 2014.  Full Article

STAAR Surgical Sees ‍Double Digit Revenue Growth In FY 2018 Over 2017
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Staar Surgical Co ::STAAR SURGICAL SEES ‍DOUBLE DIGIT REVENUE GROWTH IN FULL YEAR 2018 OVER 2017 AND ICL UNIT GROWTH RANGE 15% TO 20% FOR 2018​.  Full Article

Staar Surgical reports Q3 earnings per share $0.03
Thursday, 9 Nov 2017 

Nov 8 (Reuters) - Staar Surgical Co ::Staar Surgical reports third quarter 2017 results.Q3 adjusted earnings per share $0.04.Q3 earnings per share $0.03.Q3 sales $23.5 million versus I/B/E/S view $21.5 million.Q3 earnings per share view $-0.04 -- Thomson Reuters I/B/E/S.Staar Surgical Co - ‍cash, cash equivalents and restricted cash at September 29, 2017 totaled $16.3 million, compared to $14.1 million at end of Q4 of 2016​.  Full Article

Staar Surgical reports second quarter 2016 results
Thursday, 4 Aug 2016 

Staar Surgical Co : Q2 adjusted loss per share $0.02 . Q2 sales $21 million versus I/B/E/S view $19.9 million . Staar Surgical reports second quarter 2016 results . Q2 loss per share $0.05 . Q2 earnings per share view $-0.05 -- Thomson Reuters I/B/E/S .On-Going FDA remediation effort finished quarter on-track and on-budget.  Full Article

BRIEF-STAAR Surgical Reports Q1 EPS Of $0.01

* STAAR SURGICAL REPORTS FIRST QUARTER 2018 RESULTS; REVENUE INCREASES 33 PERCENT ON ACCELERATING EVO VISIAN ™ ICL MOMENTUM